日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HDAC6 orchestrates metastatic and immunosuppressive programs in small cell lung cancer through S100A2-TGF-β/SMAD and CSF1R signaling.

HDAC6 通过 S100A2-TGF-β/SMAD 和 CSF1R 信号传导来调控小细胞肺癌的转移和免疫抑制程序。

Jiang Yantao, Yu Junjie, Wang Ting, Du Qingwu, Wang Jingya, Lu Yi, Xu Qi, Liu Huiyan, Li Xueyang, Tong Luyao, Qin Tingting, Huang Dingzhi

Author Correction: HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype

作者更正:HDAC6 通过诱导 EMT 和增强巨噬细胞向 M2 表型极化来促进 LUAD 的进展

Jiang, Yantao; Zhang, Ju; Yu, Junjie; Luo, Wei; Du, Qingwu; Liu, Wenting; Xu, Qi; Li, Xueyang; Liu, Huiyan; Huang, Dingzhi; Qin, Tingting

Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7-driven Small Cell Lung Cancer.

核质转运是 HDAC7 驱动的小细胞肺癌中可药物靶向的依赖性因素

Qin Tingting, Wang Jingya, Wang Jian, Du Qingwu, Wang Liuchun, Liu Hailin, Liu Wenting, Li Xueyang, Jiang Yantao, Xu Qi, Yu Junjie, Liu Huiyan, Wang Ting, Li Mengjie, Huang Dingzhi

RAN potentiates nuclear export of phosphorylated AMPK, reshaping lipid metabolism and impairing immune efficacy in lung adenocarcinoma

RAN 可增强磷酸化 AMPK 的核输出,从而重塑脂质代谢并损害肺腺癌的免疫效力。

Du, Qingwu; Li, Rui; Wang, Jian; Wang, Jingya; Jiang, Yantao; Xu, Qi; Huang, Dingzhi; Qin, Tingting

HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype.

HDAC6 通过诱导 EMT 和增强巨噬细胞向 M2 表型极化来促进 LUAD 的进展

Jiang Yantao, Zhang Ju, Yu Junjie, Luo Wei, Du Qingwu, Liu Wenting, Xu Qi, Li Xueyang, Liu Huiyan, Huang Dingzhi, Qin Tingting

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma

食管鳞状细胞癌根治性放化疗期间内镜超声联合活检的预测和预后标志物

Du, Qingwu; Wu, Xiaoyue; Zhang, Kunning; Cao, Fuliang; Zhao, Gang; Wei, Xiaoying; Guo, Zhoubo; Li, Yang; Dong, Jie; Zhang, Tian; Zhang, Wencheng; Wang, Ping; Chen, Xi; Pang, Qingsong

Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma

更正:食管鳞状细胞癌根治性放化疗期间内镜超声联合活检的预测和预后标志物

Du, Qingwu; Wu, Xiaoyue; Zhang, Kunning; Cao, Fuliang; Zhao, Gang; Wei, Xiaoying; Guo, Zhoubo; Li, Yang; Dong, Jie; Zhang, Tian; Zhang, Wencheng; Wang, Ping; Chen, Xi; Pang, Qingsong

Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma.

IGFR1 和 VEGF-A 共表达在早期和局部晚期肺腺癌中的临床病理特征

Liu Wenting, Xia Junling, Du Qingwu, Wang Jingya, Mei Ting, Qin Tingting

Annual report of the esophageal cancer radiation group of the Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital

天津医科大学肿瘤医院放射治疗科食管癌放射治疗组年度报告

Pang, Qingsong; Wei, Xiaoying; Zhang, Wencheng; Zhang, Tian; Chen, Xi; Dong, Jie; Wei, Hui; Er, Puchun; Zhao, Jingjing; Han, Dong; Guo, Zhoubo; Lei, Tongda; Du, Qingwu; Guan, Yong; Wang, Jing; Zhao, Lujun; Wang, Jun; Yuan, Zhiyong; Song, Yongchun; Liu, Ningbo; Wang, Ping

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma

同步降低临床靶区剂量与调强放射治疗治疗局部晚期食管鳞状细胞癌的疗效和安全性

Zhao, Jingjing; Lei, Tongda; Zhang, Tian; Chen, Xi; Dong, Jie; Guan, Yong; Wang, Jing; Wei, Hui; Er, Puchun; Han, Dong; Wei, Xiaoying; Guo, Zhoubo; Du, Qingwu; Wang, Jun; Liu, Ningbo; Song, Yongchun; Yuan, Zhiyong; Zhao, Lujun; Zhang, Wencheng; Pang, Qingsong; Wang, Ping